Canadian Organ Replacement Registry, 1991 Report.Don Mills, Ontario, Canada: Hospital Medical Records Institute, 1993.
2.
US Renal Data System.USRDS 1991 Annual Report.Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 1991.
3.
United States Renal Data System USRDS.Annual data report. U.S. Department of Health and Human Services.Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995.
4.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1995; 6: 177–83.
5.
SiamopoulosK.C., ElisafM.S., BairaktariH.T., PappasM.B., SferopoulosG.D., NikolakakisN.G.Lipid parameters including lipoprotein(a) in patients undergoing CAPD and hemodialysis.Perit Dial Int1995; 15: 342–7.
WebbA.T., ReaveleyD.A., O'DonnellM., O'ConnorB., SeedM., BrownE.A.Lipoprotein(a) in patients maintenance hemodialysis and continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant1993; 8: 609–13.
8.
KronenbergF., KönigP., NeyerU., AuingerM., PribasnigA., LangU.Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with endstage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.J Am Soc Nephrol1995; 6: 110–20.
9.
FriedewaldW.T., LevyR.I., FredricksonD.S.Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge.Clin Chem1972; 18: 449–502.
10.
AvramM.M., FeinP.A., AntignaniA., MittmanN., MushnickR.A., LustigA.R.Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis.Am J Med1989; 87(Suppl 5N): 5–55N.
11.
FrankW.M., RaoT.K.S., ManisT., DelanoB.G., AvramM.M., SaxenaA.K.Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis.Am J Clin Nutr1978; 31: 1886–92.
12.
HaasL.B., WahlP.W., SherrardD.J.A longitudinal study of lipid abnormalities in renal failure.Nephron1983; 22: 145–9.
13.
KaganA., Bar-KhayimY., SchaferZ., FainaruM.Kinetics of peritoneal protein loss during CAPD. Part II. Lipoprotein leakage and its impact on plasma lipid levels.Kidney Int1990; 37: 980–90.
14.
AvramM.M., GoldwasserP., BurrellD.E., AntignaniA., FeinP.A., MittmanN.The uremic dyslipidemia: A crosssectional and longitudinal study.Am J Kidney Dis1992; 20: 324–35.
15.
RamosJ.M., HeatonA., McGurkJ.G., WardM.L., KerrD.N.S.Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis.Nephron1983; 35: 20–3.
16.
LindholmB., NorbeckH.E.Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis.Acta Med Scand1986; 220: 143–51.
17.
BreckenridgeW.C., RoncariD.A.K., KhannaR., OreopoulosD.G.The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins.Atherosclerosis1982; 45: 249–58.
18.
Abdel-RahmanE.M., WakeenM., ZimmermanS.W.Characteristics of long-term peritoneal dialysis survivors: 18 years experience in one center.Perit Dial Int1997; 17: 151–6.
